Piramal Finance reports Q3FY26 net profit of ₹401 crore, driven by 31% NII growth and plans for retail expansion.

MKC's fourth-quarter earnings miss estimates, but organic growth improves on gains in Consumer and Flavor Solutions.

The Zacks Consensus Estimate for Eli Lilly’s overall oncology portfolio sales during fourth-quarter 2025 is pegged at $2.64 ...

A broader set of sectors will be represented when 35 more S&P 500 companies report earnings this week, including Netflix, ...